ALLMedicine™ Tractional Retinal Detachment Center
Research & Reviews 141 results
https://doi.org/10.1038/s41433-022-02140-0 10.1016/S0002-9394(14)70899-2 10.1016/0002-9394(55)91866-3 10.1007/s00417-017-3886-4 10.1016/j.ophtha.2010.03.062 10.1097/IAE.0000000000000353 10.1136/bjo.2004.053595 10.1001/archopht.1976.03910030189003 10.1016/S0161-6420(00)00100-7 10.1016/S0161-6420(82)34854-X 10.1038/s41433-019-0345-y 10.1159/000307733 10.1001/archopht.121.9.1340 10.1177/112067210201200613
Eye (London, England); Ozdemir Zeydanli E, Ozdek S et. al.
Jun 24th, 2022 - To determine the role of vitreoretinal surgery (VRS) for two different forms of posterior persistent fetal vasculature syndrome (PFVS); with tent-shaped tractional retinal detachment (TRD) and closed funnel-shaped TRD. Retrospective, single surgeo...
https://clinicaltrials.gov/ct2/show/NCT05415826
Jun 13th, 2022 - Diabetic retinopathy is a significant source of visual morbidity in the adult population. Complications of diabetic retinopathy include ischemic maculopathy, macular edema, and sequelae of fibrovascular proliferation, such as vitreous hemorrhage (...
https://clinicaltrials.gov/ct2/show/NCT05414149
Jun 10th, 2022 - Proliferative diabetic retinopathy (PDR) is the most common causes of irreversible blindness in diabetic retinopathy (DR).It is characterized by progressive loss of vision, retinal edema, vitreous hemorrhage (VH), retinal neovascularization, fibro...
https://doi.org/10.1007/s10792-022-02227-3 10.1001/archopht.1997.01100150337005 10.1097/00006982-200104000-00002 10.1136/bjo.85.8.942 10.1016/S0886-3350(00)00864-6 10.1055/s-0029-1245271 10.1097/00006982-200502000-00008 10.1177/112067210301300705 10.1016/j.jcrs.2009.04.015 10.1016/j.ophtha.2009.04.019 10.1038/sj.eye.6700157 10.1007/s00417-003-0672-2 10.1038/eye.2012.163 10.4103/0974-9233.171755 10.1007/s00417-002-0563-y 10.1016/S0886-3350(00)00585-X 10.1038/eye.1995.60 10.1016/S0161-6420(98)91119-8 10.21608/ejhm.2020.126408 10.1016/j.ajo.2020.04.035 10.1097/00006982-200204000-00004 10.1097/00006982-200011000-00002 10.1034/j.1600-0420.2000.078002182.x 10.1136/bjo.85.11.1324 10.1097/IAE.0000000000000204 10.1136/bjo.85.10.1203
International Ophthalmology; Karimi S, Nikkhah H et. al.
Jun 9th, 2022 - To evaluate the outcomes and complications of simultaneous silicon oil removal (SOR) and phacoemulsification and intra ocular lens implantation. In this retrospective non-comparative case series, the visual, refractive and anatomical outcomes of p...
https://clinicaltrials.gov/ct2/show/NCT05408416
Jun 7th, 2022 - Proliferative diabetic retinopathy (PDR) is the most common causes of irreversible blindness in diabetic retinopathy (DR).It is characterized by progressive loss of vision, retinal edema, vitreous hemorrhage (VH), retinal neovascularization, fibro...
Clinicaltrials.gov 23 results
https://clinicaltrials.gov/ct2/show/NCT05415826
Jun 13th, 2022 - Diabetic retinopathy is a significant source of visual morbidity in the adult population. Complications of diabetic retinopathy include ischemic maculopathy, macular edema, and sequelae of fibrovascular proliferation, such as vitreous hemorrhage (...
https://clinicaltrials.gov/ct2/show/NCT05414149
Jun 10th, 2022 - Proliferative diabetic retinopathy (PDR) is the most common causes of irreversible blindness in diabetic retinopathy (DR).It is characterized by progressive loss of vision, retinal edema, vitreous hemorrhage (VH), retinal neovascularization, fibro...
https://clinicaltrials.gov/ct2/show/NCT05408416
Jun 7th, 2022 - Proliferative diabetic retinopathy (PDR) is the most common causes of irreversible blindness in diabetic retinopathy (DR).It is characterized by progressive loss of vision, retinal edema, vitreous hemorrhage (VH), retinal neovascularization, fibro...
https://clinicaltrials.gov/ct2/show/NCT02590094
Dec 3rd, 2021 - Severe vision loss in patients with proliferative diabetic retinopathy (PDR) frequently results from complications related to neovascularization and fibrovascular proliferation. Patients with PDR are typically considered candidates for pars plana ...
https://clinicaltrials.gov/ct2/show/NCT03660384
Dec 2nd, 2021 - Severe vision loss in patients with proliferative diabetic retinopathy (PDR) frequently results from complications related to neovascularization and fibrovascular proliferation. Patients with PDR are typically considered candidates for pars plana ...
News 6 results
https://www.medscape.com/viewarticle/943374
Dec 30th, 2020 - In the treatment of vitreous hemorrhage from proliferative diabetic retinopathy, intraocular injection with anti–vascular endothelial growth factor (VEGF) shows similar efficacy to that of vitrectomy with photocoagulation; however, patients common...
https://www.medpagetoday.com/primarycare/diabetes/77360?comment=true
Jan 10th, 2019 - Treatment with statins was associated with a significantly decreased risk of diabetic retinopathy in patients with type 2 diabetes and high cholesterol in a large cohort study from Taiwan. Statin therapy was also associated with a lower need for i...
https://www.medpagetoday.com/ophthalmology/generalophthalmology/68284
Oct 3rd, 2017 - One expert describes promising strategies for treating diabetic eye disease. A recent study provides new insights into how to prevent tractional retinal detachment from developing or progressing in patients with severe proliferative diabetic retin...
https://www.medpagetoday.com/ophthalmology/generalophthalmology/64073
Mar 23rd, 2017 - Action Points Many youths with type 1 and type 2 diabetes are not being screened for diabetic retinopathy in accordance with current guidelines. Note that sociodemographic factors also played a role in screening patterns, with minority youth repor...
https://www.medscape.com/viewarticle/825295
Abstract and Introduction Abstract Previous research has implicated vascular endothelial growth factor (VEGF) in the pathogenesis of diabetic retinopathy (DR). Although many studies reviewed the use of anti-VEGF for diabetic macular oedema, little...
